Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Not Yet Recruiting

Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

NCT07485647

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Not Yet Recruiting

Multiple Myeloma t(4 ;14) FFPE Samples

NCT07482761

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: BIWAKO Lyon, France

View Trial Details

Not Yet Recruiting

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

NCT07474961

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Copenhagen University Hospital - Rigshospitalet Copenhagen, Greater Copenhagen Area, Denmark

Aalborg University Hospital Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Not Yet Recruiting

Nemtabrutinib, Bortezomib, and Rituximab for WM

NCT07464210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Not Yet Recruiting

Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

NCT07458659

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: King Chulalongkorn Memorial Hospital Bangkok, Pathumwan, Thailand

View Trial Details

Not Yet Recruiting

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

NCT07029776

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Not Yet Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Not Yet Recruiting

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

NCT07336472

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

NCT07426484

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial.

NCT07421856

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions